XML 109 R83.htm IDEA: XBRL DOCUMENT v3.19.1
Financial Schedules Schedule II - Statement of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Net income (loss) $ (1,432) $ (7,109) $ (2,558) $ 37 $ (44,204) $ 3,449 $ 572 $ 2,056 $ (11,062) $ (38,127) $ 1,969
Realized investment gains (losses), net                 (108) (518) 1,985
Amortization of premiums and discounts on investments                 16,998 16,606 14,676
Depreciation                 1,451 1,065 806
Accrued investment income                 595 (1,159) (2,497)
Other, net                 (752) 59 224
Net cash provided by operating activities                 84,620 93,012 102,271
Purchase of fixed maturities, available-for-sale                 (195,001) (167,699) (234,964)
Maturities of fixed maturities, available-for-sale                 65,906 74,902 56,032
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale                 38,823 1,077 20,638
Sale of other long-term investments and property and equipment                 14 3,041 37
Purchase of other long-term investments and property and equipment                 0 0 (75)
Purchase of short-term investments                 (7,850) 0 (522)
Maturity of short-term investments                 0 500 256
Net cash used in investing activities                 (85,134) (85,005) (152,077)
Net cash provided by financing activities                 (58) 2,547 2,489
Net increase (decrease) in cash and cash equivalents                 (572) 10,554 (47,317)
Cash and cash equivalents at beginning of year       46,064       35,510 46,064 35,510 82,827
Cash and cash equivalents at end of year 45,492       46,064       45,492 46,064 35,510
Parent Company [Member]                      
Net income (loss)                 (11,062) (38,127) 1,969
Realized investment gains (losses), net                 196 0 0
Equity in income of consolidated subsidiaries                 10,691 38,745 (1,288)
Accrued expenses and other liabilities                 (2,036) 4,370 (3,018)
Amortization of premiums and discounts on investments                 567 714 911
Depreciation                 356 319 162
Accrued investment income                 (46) 181 35
Decrease (increase) in receivable from subsidiaries                 382 (2,901) 300
Other, net                 22 (102) 149
Net cash provided by operating activities                 (930) 3,199 (780)
Purchase of fixed maturities, available-for-sale                 (11,871) 0 (6,615)
Maturities of fixed maturities, available-for-sale                 7,160 10,986 8,015
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale                 1,366 0 0
Sale of other long-term investments and property and equipment                 103 3 371
Purchase of other long-term investments and property and equipment                 (60) (261) (740)
Purchase of short-term investments                 (7,850) 0 (522)
Maturity of short-term investments                 0 500 0
Capital contribution to subsidiary                 0 (5,250) 0
Net cash used in investing activities                 (11,152) 5,978 509
Purchase of the Company's stock from affiliates                 0 0 (812)
Net cash provided by financing activities                 0 0 (812)
Net increase (decrease) in cash and cash equivalents                 (12,082) 9,177 (1,083)
Cash and cash equivalents at beginning of year       $ 23,850       $ 14,673 23,850 14,673 15,756
Cash and cash equivalents at end of year $ 11,768       $ 23,850       $ 11,768 $ 23,850 $ 14,673